SanBio Company (TYO:4592) has secured a new committed credit line of 1 billion yen from Mizuho Bank (TYO:8411) to fund manufacturing, distribution, and marketing infrastructure for Akuugo, which received conditional approval in July 2024.
The agreement, effective June 2025 through November 2026, complements an existing 1 billion yen credit line from Resona Bank covering similar purposes until March 2027.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。